Fig. 1: Transition metal-catalyzed functionalization/cyclization of 1,6-enynes.

a Bioactive molecules containing chiral 2-pyrrolidone and 1,2,3,6-tetrahydropyridine skeletons. b Enantioselective cyclization of 1,6-enynes via carbometallation/cyclization/elimination pathway.